Published in
BioMed Central, Trials, 1(13), 2012
Links
- BioMed Central | PDF
- ORCID
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Rationale and design of the RIACT-study: A multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: Study protocol for a randomized controlled trial
Journal article published in 2012 by
Lena Schiffer,
Mario Schiffer 
,
Saskia Merkel,
Anke Schwarz,
Michael Mengel,
Christopher Jürgens,
Christoph Schroeder,
Alexander A. Zoerner,
Kerstin Püllmann,
Verena Bröcker,
Jan U. Becker,
Maximilian E. Dämmrich,
Jana Träder,
Anika Großhennig,
Frank Biertz
and other authors.
,
Saskia Merkel,
Anke Schwarz,
Michael Mengel,
Christopher Jürgens,
Christoph Schroeder,
Alexander A. Zoerner,
Kerstin Püllmann,
Verena Bröcker,
Jan U. Becker,
Maximilian E. Dämmrich,
Jana Träder,
Anika Großhennig,
Frank Biertz
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 